More Articles
Update to the Vosoritide (Voxzogo TM) indication in USA On October 20, 2023 US Food and Drug Administration (FDA) has extended approval of Voxzogo to children with Achondroplasia of all…
Read MoreNew Meds and Tech from PES Drugs and Therapeutics committee SKYTROFA® Anna Ryabets-Lienhard, DO, Christine Yu, MD, Emily Breidbart, MD In August 2021, FDA approved SKYTROFA® (lonapegsomatropin-tcgd), the first…
Read MorePublic Policy Spotlight This spotlight will highlight recent articles both in lay and academic press that The PES Leadership believe would be of use to our constituents. Physicians as…
Read MoreHistorical Tidbit: H. Franklin Bunn (July 7, 1935- ) Submitted by Alan D. Rogol, MD, Ph.D Franklin Bunn, a hematologist noted (with Gabbay and Gallop) that the most abundant, fast-moving…
Read MoreWhat is your current position/how do you spend your time? I’m a third-year pediatric endocrinology fellow at the University of North Carolina in Chapel Hill. I’m in my last month…
Read MoreNew: Public Policy Spotlight We are providing the following articles/links on transgender care for members who want to be kept current or better understand the issues in Texas and Alabama…
Read MoreSabitha Sasidharan Pillai, MD I am a second-year pediatric endocrinology fellow at the Hasbro Children’s Hospital and Brown University in Providence, RI. My time is split between clinical work and research.…
Read MoreDr. Juan Sotos –May 18 1927-May 7, 2022 It is with sadness that we share the news of the death May 7th of Dr. Juan Sotos. Dr. Sotos was truly…
Read More